| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,065 |
781 |
$45K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
626 |
319 |
$22K |
| 96367 |
|
843 |
440 |
$16K |
| 80053 |
Comprehensive metabolic panel |
2,177 |
1,256 |
$12K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,733 |
1,524 |
$11K |
| 82575 |
|
2,167 |
1,253 |
$10K |
| 83735 |
|
2,142 |
1,231 |
$7K |
| 83615 |
|
2,169 |
1,249 |
$7K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
364 |
317 |
$5K |
| 84100 |
|
2,167 |
1,247 |
$5K |
| 84550 |
|
2,165 |
1,242 |
$5K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
104 |
82 |
$3K |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
559 |
348 |
$2K |
| 96368 |
|
330 |
190 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
1,676 |
1,146 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
87 |
52 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
73 |
66 |
$2K |
| 96415 |
|
70 |
38 |
$1K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
37 |
24 |
$798.51 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,341 |
824 |
$492.78 |
| 96523 |
|
226 |
60 |
$302.55 |
| 82728 |
|
16 |
12 |
$185.19 |
| 83550 |
|
16 |
12 |
$118.67 |
| 83540 |
|
16 |
12 |
$87.90 |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
110 |
70 |
$50.37 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
36 |
13 |
$29.34 |